Hanson Wade

R&D

Partner Content

5th Gamma Delta T Cell Therapies Summit

The 5th Gamma Delta T Cell Therapies Summit will bring together experts from big pharma, biotech and academia to delve into the details of gamma delta biology and its various subsets to off

R&D

Partner Content

Next Gen Peptide Formulation & Delivery Summit

Exciting developments in the world of peptides!

R&D

Partner Content

13th HPAPI: Process Development for Highly Potent Drugs

The rise in novel, more potent compounds, alongside EU Annex 1, are mounting pressure on biopharma, CDMOs and equipment providers to evolve their industrial hygiene, process engineering and

R&D

Partner Content

3rd In Vivo Cell Engineering & Gene Editing Summit

Achieve Safe & Targeted In Vivo Delivery of Payloads with Clarity in Regulations & Appropriate Models to Advance the Next Frontier of In Vivo Editing from Research to Clinic

R&D

Partner Content

6th Cell Engager Therapeutics Summit 2024

Advancing the Development of Novel Targets, Safe, & Effective Multi-Specific Immune Cell Engagers for Solid & Liquid Tumors in the Clinic

R&D

Partner Content

4th mRNA-Based Therapeutics Summit

Fast-Track Your mRNA-Based Therapeutics & Vaccines from Discovery to Commercialisation by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indica

5th Gamma Delta T Cell Therapies Summit

Next Gen Peptide Formulation & Delivery Summit

13th HPAPI: Process Development for Highly Potent Drugs

3rd In Vivo Cell Engineering & Gene Editing Summit

6th Cell Engager Therapeutics Summit 2024

4th mRNA-Based Therapeutics Summit

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

Hanson Wade

Editor's Picks